Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 961-966

  Schalm, Solko W ^a   Hansen, Bettina E ^a   Chemello, Liliana ^a   Bellobuono, Antonio ^a   Brouwer, Johannes T ^a   Weiland, Ole ^a   Cavalletto, Luisa ^a   Schvarcz, Robert ^a   Ideo, Gaetano ^a   Alberti, Alfredo ^a  

^a NONE

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis C; Interferon; Meta analysis; Ribavirin; Therapy

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ANEMIA; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG EFFICACY; DRUG POTENTIATION; FATIGUE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; TREATMENT OUTCOME;

EID: 0030979346     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80103-1     Document Type: Article

References (16)

1. Jouet P, Roudot-Thoraval F, Dhumeaux D, Metreau JM. Comparative efficacy of interferon-alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology. 106:1994;686-690.
2. Alberti A, Chemello L, Bonetti P, Casarin C, Diodati G, Cavalletto L, Cavalletto D, Frezza M, Donada C, Belussi F, Casarin P, Pozzato G, Ruol A. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. J Hepatol. 17:1993;S123-S126. (Suppl. 3).
3. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM, Vidaud M, Chaput JC. A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med. 332:1995;1457-1462.
4. Reichard O, Andersson J, Schvarcz R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet. 337:1991;1058-1061.
5. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L. A pilot study of combination therapy with ribavirin plus interferon alpha for alpha-interferon resistant chronic hepatitis C. Gastroenterology. 107:1994;812-817.
6. Brouwer JT, Nevens F, Michielsen P, Hautekeete ML, Chamuleau RAF, Adler M, Delwaide J, Heijtink RA, Schalm SW. What options are left when hepatitis C does not respond to Interferon? Placebo controlled Benelux multicentre trial on Ribavirin mono-therapy versus prolonged combination with Interferon. J Hepatol. 21:1994;S17.
7. Chemello L, Cavaletto L, Bernardinello E, Silvestri E, Benvegnu L, Pontisso P, Albert A. Response to ribavirin, to interferon and to a combination of both in patients with chronic hepatitis C and its relation to HCV genotypes. J Hepatol. 21:1994;S12.
8. Bellobuono A, Tempini S, Bellati G, Asti L, Ideo G. Ribavirin followed by alpha interferon in chronic hepatitis C resistant to therapy. Gastroenterology. 108:1995;A 1033.
9. Schvarcz R, Ando Y, Sönnerborg A, Weiland O. Combination treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. J Hepatol. 23:1995;17-21. (Suppl 2).
10. Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Sung JL, Chen DS. Combination therapy of ribavirin plus interferon alpha for chronic hepatitis C. Presented at the Annual Meeting of Japan Society of Hepatology. 1995.
11. Altman DT. Practical Statistics for Medical Research. 1992;Chapman & Hall, London.
12. Metha CR, Patel NR. Exact logistic regression: theory, application and software. Proc 10th Symposium Comp Statist. 1992;63-78.
13. Cambridge MA. LogXact-Turbo. 1993;Cytel Software Corporation.
14. Marcellin P, Pouteau M, Martinot-Peignoux M, Degos F, Duchatelle V, Boyer N, Lemonnier C, Degott C, Erlinger S, Benhamou JP. Lack of benefit of escalating dosage of interferon alpha in patients with chronic hepatitis C. Gastroenterology. 109:1995;156-165.
15. Chemello L, Cavalletto L, Noventa F, Bonetti P, Casarin C, Bernardinello E, Pontisso P, Donada C, Casarin P, Belussi F, Frezza M, Alberti A. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-α J Viral Hepat. 2:1995;91-96.
16. Friedman HP, Goldberg JD. Meta-analysis: an introduction and point of view. Hepatology. 23:1996;917-928.